Heywood R, James R W, Sortwell R J
Toxicology. 1978 Nov;11(3):245-50. doi: 10.1016/s0300-483x(78)91489-0.
A toxicological investigation was performed with the linear alkylbenzene sulphonate (LAS) using 4 groups of 3 male and 3 female monkeys. Dosages were 0, 30, 150, 300 and 0, 0.1, 0.5, 1.0 mg/kg/day by simultaneous oral (p.o.) and subcutaneous (s.c.) administration respectively, for 28 days. At 300 p.o. and 1.0 s.c. mg/kg/day, the monkeys vomited frequently and usually within 3 hours of administration. An increased frequency of loose or liquid faeces was recorded for animals receiving 150 p.o. and 0.5 s.c. and 300 p.o. and 1.0 s.c. mg/kg/day. Fibrosis of the injection sites was found among all the test groups, the incidence and severity being dose related. Ophthalmoscopy, laboratory examination of blood and urine, organ-weight analysis and histopathological investigation did not detect any further treatment related responses. Previous reports concerning oral administration of tetrapropylene benzene sulphonates (ABS) to dogs record prompt emesis ascribed to local gastro-intestinal effects. Vomiting observed during this investigation was considered to be of possible central origin.
使用4组,每组3只雄性和3只雌性猴子,对直链烷基苯磺酸盐(LAS)进行了毒理学研究。剂量分别为0、30、150、300毫克/千克/天和0、0.1、0.5、1.0毫克/千克/天,分别通过口服(p.o.)和皮下(s.c.)同时给药,持续28天。在口服300毫克/千克/天和皮下注射1.0毫克/千克/天时,猴子频繁呕吐,通常在给药后3小时内发生。接受口服150毫克/千克/天和皮下注射0.5毫克/千克/天以及口服300毫克/千克/天和皮下注射1.0毫克/千克/天的动物,记录到稀便或水样便的频率增加。在所有试验组中均发现注射部位纤维化,其发生率和严重程度与剂量相关。眼底检查、血液和尿液实验室检查、器官重量分析和组织病理学研究均未发现任何与治疗相关的进一步反应。先前有关给狗口服四聚丙烯苯磺酸盐(ABS)的报告记录了归因于局部胃肠道效应的迅速呕吐。本次研究中观察到的呕吐被认为可能起源于中枢。